ENTRY       D11521            Mixture   Drug
NAME        Lamivudine, nevirapine and zidovudine
COMPONENT   Lamivudine [DR:D00353], Nevirapine [DR:D00435], Zidovudine [DR:D00413]
CLASS       Antiviral
             DG03107  Anti-HIV agent
            Metabolizing enzyme substrate
             DG02919  CYP2B6 substrate
             DG01633  CYP3A/CYP3A4 substrate
             DG02924  UGT substrate
            Metabolizing enzyme inducer
             DG02891  CYP2B6 inducer
             DG02853  CYP3A/CYP3A4 inducer
            Transporter substrate
             DG02854  SLC22A2 substrate
             DG02964  SLC47A1 substrate
             DG03002  SLC47A2 substrate
REMARK      ATC code: J05AR05
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
COMMENT     Lamivudine is a substrate of OCT2, MATE1 and MATE2-K.
            Nevirapine is a substrate and an inducer of CYP3A and CYP2B6.
            Zidovudine is metabolized by UDP-glucuronosyltransferase (UGT).
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551], CYP2B6 [HSA:1555], UGT [KO:K00699]
            Transporter: SLC22A2 [HSA:6582], SLC47A1 [HSA:55244], SLC47A2 [HSA:146802]
INTERACTION CYP induction: CYP3A [HSA:1576 1577 1551], CYP2B6 [HSA:1555]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR05 Zidovudine, lamivudine and nevirapine
                  D11521  Lamivudine, nevirapine and zidovudine
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D11521  Lamivudine, nevirapine and zidovudine
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               D11521  Lamivudine, nevirapine and zidovudine
              DG01633  CYP3A/CYP3A4 substrate
               D11521  Lamivudine, nevirapine and zidovudine
              DG02924  UGT substrate
               D11521  Lamivudine, nevirapine and zidovudine
             Metabolizing enzyme inducer
              DG02891  CYP2B6 inducer
               D11521  Lamivudine, nevirapine and zidovudine
              DG02853  CYP3A/CYP3A4 inducer
               D11521  Lamivudine, nevirapine and zidovudine
             Transporter substrate
              DG02854  SLC22A2 substrate
               D11521  Lamivudine, nevirapine and zidovudine
              DG02964  SLC47A1 substrate
               D11521  Lamivudine, nevirapine and zidovudine
              DG03002  SLC47A2 substrate
               D11521  Lamivudine, nevirapine and zidovudine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D11521  Lamivudine, nevirapine and zidovudine
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11521
             Drug transporters
              D11521
DBLINKS     PubChem: 384585497
///
